By leveraging advanced delivery systems and exploring mechanisms like epigenetic regulation (e.g., HDAC inhibition and MALAT1 targeting), polyphenols may redefine cancer treatment as low-toxicity, multitarget agents capable of overcoming drug resistance and improving patient outcomes. The gene discussed is MALAT1; the disease is cancer.